Teladoc Health Stock Forecast

Stock Price Forecast

According to 23 analysts polled by S&P Global, Teladoc Health stock has a consensus rating of "Hold" and an average price target of $8.58. The average 1-year stock price forecast is 11.47% lower than the current stock price, while the lowest is $6.00 (-38.11%) and the highest is $11.5 (+18.62%).

Price Target: $8.58 (-11.47%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$6.00	$8.58	$8.75	$11.5
Change	-38.11%	-11.47%	-9.75%	+18.62%

Analyst Ratings

The average analyst rating for Teladoc Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	6	5	5	5	5	5
Buy	1	1	1	1	1	1
Hold	18	18	18	17	17	16
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	1
Total	25	24	24	23	23	23

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Peter Warendorf Barclays	Barclays	Hold Maintains $7 → $9	Hold	Maintains	$7 → $9	-7.17%	Nov 4, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Hold Maintains $7.5 → $8.5	Hold	Maintains	$7.5 → $8.5	-12.33%	Nov 2, 2026
David Toung Argus Research	Argus Research	Sell Downgrades n/a	Sell	Downgrades	n/a	n/a	Nov 2, 2026
Michael Wiederhorn Oppenheimer	Oppenheimer	Buy Maintains $7 → $10	Buy	Maintains	$7 → $10	+3.15%	Nov 2, 2026
Kevin Caliendo UBS	UBS	Hold Reiterates $6.5 → $9	Hold	Reiterates	$6.5 → $9	-7.17%	Nov 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.42B

from 2.53B

-4.42%

from 2.53B

Revenue Next Year

2.35B

from 2.42B

-2.79%

from 2.42B

EPS This Year

-0.68

from -0.66

EPS Next Year

-0.63

from -0.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.03B	2.41B	2.60B	2.57B	2.53B	2.42B
Revenue Growth	85.81%	18.41%	8.13%	-1.26%	-1.54%	-4.42%
Gross Profit	1.38B	1.66B	1.84B	1.82B	1.76B	1.65B
Gross Margin	68.01%	69.09%	70.80%	70.76%	69.50%	68.30%
Operating Income	-238.99M	-217.47M	-210.50M	-208.79M	-163.40M	-150.25M
Net Income	-428.79M	-13.66B	-220.37M	-1.00B	-200.32M	-149.99M
EPS	-	-	-	-	-0.66	-0.68
Free Cash Flow	-	-	-	-	166.90M	146.66M
No. Analysts	-	-	-	-	-	20

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.4B
Avg	2.4B
Low	2.4B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-3.6%
Avg	-4.4%
Low	-6.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.39
Avg	-0.68
Low	-1.03

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-